Brainstem electronic implants for bilateral anacusis following surgical removal of cerebello pontine angle lesions.

The multichannel auditory brainstem implant (ABI) has been used successfully to treat deafness in individuals with neurofibromatosis type II. The device has been implanted in nearly 150 recipients worldwide, and clinical trials with the device are approaching completion. The implantation and fitting of the multichannel ABI differ significantly from cochlear implantation, and the processes are illustrated in a series of case studies. Performance data also are included from recipients with up to 7 years experience.

Twenty-year report of the first auditory brain stem nucleus implant.

We present the 20-year case report of an auditory implant placed on the dorsal cochlear nucleus with long-term electrical stimulation in a patient with neurofibromatosis 2. The patient has continued to use her implant daily for 20 years, and it has greatly enhanced her quality of life. There have been no adverse sequelae.

Direct cochlear nerve action potentials as an aid to hearing preservation in middle fossa acoustic neuroma resection.

A new application of auditory evoked potentials using direct cochlear nerve action potentials (CNAPs) for monitoring middle fossa acoustic neuroma resection with attempted hearing preservation is described. Twenty patients have been studied to date. With this technique, a monitoring electrode is secured between the floor of the internal auditory canal and the dura adjacent to the cochlear nerve in an extradural location. Standard auditory evoked potential techniques with click stimuli and microelectrical recording allow observation of nearfield waveforms in seconds versus several minutes required for farfield potentials recorded from the scalp. Advantages of this technique over auditory brainstem response monitoring may include nearly real time measurement of potentials, improved surgeon learning curve and possibly higher rates of hearing preservation, and applicability to all patients undergoing hearing-preservation surgery independent of presence or absence of ABR tracing. Immediate changes in amplitude and latency of waveforms appear to compare with reversible and irreversible intraoperative auditory system damage, thereby guiding surgical maneuvers.

Middle fossa decompression of the internal auditory canal in acoustic neuroma surgery: a therapeutic alternative.

Unilateral acoustic neuromas in only-hearing ears and bilateral acoustic neuromas (NF-2) are separate entities, but both pose a common problem because surgical removal has the potential to leave the patient totally deafened. A middle fossa decompression of the internal auditory canal (IAC) was performed in 8 patients (5 with NF-2 tumors and 3 with neuromas in an only-hearing ear). In 5 of the 8, the speech discrimination scores at the 6-month follow-up were better than preoperative scores. After 6 months, however, hearing regressed at variable rates. Although not a definitive therapeutic treatment, decompression of the IAC appears to improve and perhaps prolong useful hearing, which gains valuable time for rehabilitation. Rigid follow-up by computed tomography scans or magnetic resonance imaging is essential.

Electrical stimulation of cochlear nucleus in man.

Auditory percepts can be produced by electrical stimulation of the cochlear nucleus in man. The ability to locate accurately and stimulate selectively the cochlear nucleus after removal of an acoustic schwannoma was confirmed in this patient. The surgical approach, electrode design, and a discussion of the results and concerns of electrical stimulation are reviewed.